Study finds MS drug costs skyrocketed for Medicare and patients

According to research recently published in JAMA, it found Multiple sclerosis patients felt the impact of rising list prices for their medications with the typical Medicare out-of-pocket costs ballooned from $372 to $2673 over a decade. The average list prices from 2006 and 2016, more than quadrupled from less than $20,000 a year to slightly more than $75,000. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.